Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Bjørg Sjøblom
Institution:
Oslo University Hospital
Observed institutions:
Oslo University Hospital,
University of Oslo,
Innlandet Hospital Trust,
Inland Hospital
OpenAlex ID:
A5085644496
Muscle mass and association to quality of life in non‐small cell lung cancer patients
2017
·
Asta Bye
, Bjørg Sjøblom
, et al.
·
Journal of Cachexia Sarcopenia and Muscle
·
166
PDF
Skeletal muscle radiodensity is prognostic for survival in patients with advanced non-small cell lung cancer
2016
·
Bjørg Sjøblom
, Bjørn H. Grønberg
, et al.
·
Clinical Nutrition
·
158
Low muscle mass is associated with chemotherapy-induced haematological toxicity in advanced non-small cell lung cancer
2015
·
Bjørg Sjøblom
, Bjørn H. Grønberg
, et al.
·
Lung Cancer
·
93
Drug Dose Per Kilogram Lean Body Mass Predicts Hematologic Toxicity From Carboplatin-Doublet Chemotherapy in Advanced Non–Small-Cell Lung Cancer
2016
·
Bjørg Sjøblom
, Jūratė Šaltytė Benth
, et al.
·
Clinical Lung Cancer
·
65
A comparison of CT based measures of skeletal muscle mass and density from the Th4 and L3 levels in patients with advanced non-small-cell lung cancer
2018
·
Bjørn H. Grønberg
, Bjørg Sjøblom
, et al.
·
European Journal of Clinical Nutrition
·
37
Associations between severe co‐morbidity and muscle measures in advanced non‐small cell lung cancer patients
2019
·
Bjørn H. Grønberg
, Christine Damgaard Valan
, et al.
·
Journal of Cachexia Sarcopenia and Muscle
·
11
PDF
Muscle measure in advanced non-small cell lung cancer: Associations with survival and treatment toxicity
2017
·
Bjørg Sjøblom
·
NVA (Nasjonalt vitenarkiv)
Show more works
View as search
Works count:
6
Citation count:
530
H-index:
6
I10-index:
6
Year
Topic
Type